This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Mar 1;180(3):173-176.

doi: 10.1176/appi.ajp.20230041.

Insights and Advances Into Treatments for Major Depression

Affiliations

PMID: 36855877
DOI: 10.1176/appi.ajp.20230041

Editorial

Insights and Advances Into Treatments for Major Depression

Ned H Kalin. Am J Psychiatry. 2023.

. 2023 Mar 1;180(3):173-176.

doi: 10.1176/appi.ajp.20230041.

Author

Affiliation

¹ Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison.

PMID: 36855877
DOI: 10.1176/appi.ajp.20230041

No abstract available

Keywords: Depressive Disorders; antidepressants; neurostimulation; pharmacotherapy.

PubMed Disclaimer

Comment on

Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
Jha MK, Mathew SJ. Jha MK, et al. Am J Psychiatry. 2023 Mar 1;180(3):190-199. doi: 10.1176/appi.ajp.20230025. Am J Psychiatry. 2023. PMID: 36855876 Review.

Similar articles

Neuroscientific Advances Supporting New Treatments for Major Depression.
Kalin NH. Kalin NH. Am J Psychiatry. 2022 Jul;179(7):441-444. doi: 10.1176/appi.ajp.20220445. Am J Psychiatry. 2022. PMID: 35775157 No abstract available.
Emerging antidepressants to treat major depressive disorder.
Block SG, Nemeroff CB. Block SG, et al. Asian J Psychiatr. 2014 Dec;12:7-16. doi: 10.1016/j.ajp.2014.09.001. Epub 2014 Sep 16. Asian J Psychiatr. 2014. PMID: 25277330 Review.
[Combination and Augmentation Pharmacotherapy and Polypharmacy in Patients with Major Depressive Disorder and Bipolar Disorder].
Matsuo K. Matsuo K. Seishin Shinkeigaku Zasshi. 2017;119(3):192-199. Seishin Shinkeigaku Zasshi. 2017. PMID: 30620855 Japanese.
[The importance of the ketamine in depressive disorders].
Filip M, Jasionowska J, Gałecki P. Filip M, et al. Pol Merkur Lekarski. 2018 Sep 21;45(267):134-136. Pol Merkur Lekarski. 2018. PMID: 30240385 Review. Polish.
Pharmacotherapy of major depressive disorder in adolescents.
Masi G, Liboni F, Brovedani P. Masi G, et al. Expert Opin Pharmacother. 2010 Feb;11(3):375-86. doi: 10.1517/14656560903527226. Expert Opin Pharmacother. 2010. PMID: 20102303 Review.

See all similar articles

Cited by

Exploring the Potential of Saffron as a Therapeutic Agent in Depression Treatment: A Comparative Review.
Chauhan S, Tiwari A, Verma A, Padhan PK, Verma S, Gupta PC. Chauhan S, et al. Yale J Biol Med. 2024 Sep 30;97(3):365-381. doi: 10.59249/XURF4540. eCollection 2024 Sep. Yale J Biol Med. 2024. PMID: 39351321 Free PMC article. Review.
An "Awakener" Patient Suffering From Treatment-Resistant Depression Following Adjunctive Cariprazine.
Bonotis K. Bonotis K. Cureus. 2024 Jan 30;16(1):e53246. doi: 10.7759/cureus.53246. eCollection 2024 Jan. Cureus. 2024. PMID: 38425604 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon